Hepatitis D diagnostics:Utilization and testing in the United States

Parham Safaie, Sanam Razeghi, Susan D. Rouster, Isaac Privitera, Kenneth E. Sherman

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Hepatitis D virus (HDV) infection may accompany acute or chronic hepatitis B virus infection. While HDV infection in the United States is thought to be uncommon, there are limited data regarding frequency of testing, and prevalence of HDV antibody and HDV RNA. We evaluated the use of HDV antibody testing using electronic medical record (EMR) data. Among 1007 HBsAg positive patients, only 121 had been tested for HDV antibody. Testing was performed primarily by gastroenterologists/hepatologists and limited testing was performed in identifiable high risk groups including those with HBV/HIV coinfection. Overall, HDV antibody was detected in 3.3% (95% C.I. = 0.9%–8.2%) An HDV RNA assay was developed and validated and 138 HBV or HBV/HIV coinfected patients were tested. The prevalence of HDV among the HBV/HIV coinfected subjects was 2.2% (95% C.I. = 0–5.3%). In a U.S. Midwestern population of HBV infected patients, HDV testing is under-employed. Overall prevalence exceeds 2% whether testing by antibody or HDV RNA and more comprehensive HDV surveillance may be indicated.

Original languageEnglish (US)
Pages (from-to)114-117
Number of pages4
JournalVirus Research
Volume250
DOIs
StatePublished - May 2 2018

Fingerprint

Hepatitis D
Hepatitis Delta Virus
Virus Diseases
Antibodies
HIV
Electronic Health Records
Chronic Hepatitis B
Hepatitis B Surface Antigens
Coinfection
Hepatitis B virus

All Science Journal Classification (ASJC) codes

  • Virology
  • Infectious Diseases
  • Cancer Research

Cite this

Safaie, Parham ; Razeghi, Sanam ; Rouster, Susan D. ; Privitera, Isaac ; Sherman, Kenneth E. / Hepatitis D diagnostics:Utilization and testing in the United States. In: Virus Research. 2018 ; Vol. 250. pp. 114-117.
@article{1700e3ca760c4d5e9606160460a0761c,
title = "Hepatitis D diagnostics:Utilization and testing in the United States",
abstract = "Hepatitis D virus (HDV) infection may accompany acute or chronic hepatitis B virus infection. While HDV infection in the United States is thought to be uncommon, there are limited data regarding frequency of testing, and prevalence of HDV antibody and HDV RNA. We evaluated the use of HDV antibody testing using electronic medical record (EMR) data. Among 1007 HBsAg positive patients, only 121 had been tested for HDV antibody. Testing was performed primarily by gastroenterologists/hepatologists and limited testing was performed in identifiable high risk groups including those with HBV/HIV coinfection. Overall, HDV antibody was detected in 3.3{\%} (95{\%} C.I. = 0.9{\%}–8.2{\%}) An HDV RNA assay was developed and validated and 138 HBV or HBV/HIV coinfected patients were tested. The prevalence of HDV among the HBV/HIV coinfected subjects was 2.2{\%} (95{\%} C.I. = 0–5.3{\%}). In a U.S. Midwestern population of HBV infected patients, HDV testing is under-employed. Overall prevalence exceeds 2{\%} whether testing by antibody or HDV RNA and more comprehensive HDV surveillance may be indicated.",
author = "Parham Safaie and Sanam Razeghi and Rouster, {Susan D.} and Isaac Privitera and Sherman, {Kenneth E.}",
year = "2018",
month = "5",
day = "2",
doi = "10.1016/j.virusres.2018.03.013",
language = "English (US)",
volume = "250",
pages = "114--117",
journal = "Virus Research",
issn = "0168-1702",
publisher = "Elsevier",

}

Hepatitis D diagnostics:Utilization and testing in the United States. / Safaie, Parham; Razeghi, Sanam; Rouster, Susan D.; Privitera, Isaac; Sherman, Kenneth E.

In: Virus Research, Vol. 250, 02.05.2018, p. 114-117.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Hepatitis D diagnostics:Utilization and testing in the United States

AU - Safaie, Parham

AU - Razeghi, Sanam

AU - Rouster, Susan D.

AU - Privitera, Isaac

AU - Sherman, Kenneth E.

PY - 2018/5/2

Y1 - 2018/5/2

N2 - Hepatitis D virus (HDV) infection may accompany acute or chronic hepatitis B virus infection. While HDV infection in the United States is thought to be uncommon, there are limited data regarding frequency of testing, and prevalence of HDV antibody and HDV RNA. We evaluated the use of HDV antibody testing using electronic medical record (EMR) data. Among 1007 HBsAg positive patients, only 121 had been tested for HDV antibody. Testing was performed primarily by gastroenterologists/hepatologists and limited testing was performed in identifiable high risk groups including those with HBV/HIV coinfection. Overall, HDV antibody was detected in 3.3% (95% C.I. = 0.9%–8.2%) An HDV RNA assay was developed and validated and 138 HBV or HBV/HIV coinfected patients were tested. The prevalence of HDV among the HBV/HIV coinfected subjects was 2.2% (95% C.I. = 0–5.3%). In a U.S. Midwestern population of HBV infected patients, HDV testing is under-employed. Overall prevalence exceeds 2% whether testing by antibody or HDV RNA and more comprehensive HDV surveillance may be indicated.

AB - Hepatitis D virus (HDV) infection may accompany acute or chronic hepatitis B virus infection. While HDV infection in the United States is thought to be uncommon, there are limited data regarding frequency of testing, and prevalence of HDV antibody and HDV RNA. We evaluated the use of HDV antibody testing using electronic medical record (EMR) data. Among 1007 HBsAg positive patients, only 121 had been tested for HDV antibody. Testing was performed primarily by gastroenterologists/hepatologists and limited testing was performed in identifiable high risk groups including those with HBV/HIV coinfection. Overall, HDV antibody was detected in 3.3% (95% C.I. = 0.9%–8.2%) An HDV RNA assay was developed and validated and 138 HBV or HBV/HIV coinfected patients were tested. The prevalence of HDV among the HBV/HIV coinfected subjects was 2.2% (95% C.I. = 0–5.3%). In a U.S. Midwestern population of HBV infected patients, HDV testing is under-employed. Overall prevalence exceeds 2% whether testing by antibody or HDV RNA and more comprehensive HDV surveillance may be indicated.

UR - http://www.scopus.com/inward/record.url?scp=85046377621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046377621&partnerID=8YFLogxK

U2 - 10.1016/j.virusres.2018.03.013

DO - 10.1016/j.virusres.2018.03.013

M3 - Article

C2 - 29596839

AN - SCOPUS:85046377621

VL - 250

SP - 114

EP - 117

JO - Virus Research

JF - Virus Research

SN - 0168-1702

ER -